Literature DB >> 24318772

Acute, reproductive toxicity and two-generation teratology studies of a standardized quassinoid-rich extract of Eurycoma longifolia Jack in Sprague-Dawley rats.

Bin-Seng Low1, Prashanta Kumar Das, Kit-Lam Chan.   

Abstract

The roots of Eurycoma longifolia Jack are popularly sought as herbal medicinal supplements to improve libido and general health amongst the local ethnic population. The major quassinoids of E. longifolia improved spermatogenesis and fertility but toxicity studies have not been well documented. The reproductive toxicity, two generation of foetus teratology and the up-and-down acute toxicity were investigated in Sprague-Dawley rats orally treated with quassinoid-rich E. longifolia extract (TAF273). The results showed that the median lethal dose (LD50 ) of TAF273 for female and male rats was 1293 and >2000 mg/kg, respectively. Fertility index and litter size of the TAF273 treated were significantly increased when compared with those of the non-treated animals. The TAF273-treated dams decreased in percentage of pre-implantation loss, post-implantation loss and late resorption. No toxic symptoms were observed on the TAF273-treated pregnant female rats and their foetuses were normal. The no-observed adverse effect level (NOAEL) obtained from reproductive toxicity and teratology studies of TAF273 in rats was 100 mg/kg body weight/day, being more than 10-fold lower than the LD50 value. Thus, any human dose derived from converting the rat doses of 100 mg/kg and below may be considered as safe for further clinical studies.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Eurycoma longifolia Jack; acute toxicity; quassinoids; reproductive toxicity; teratology

Mesh:

Substances:

Year:  2013        PMID: 24318772     DOI: 10.1002/ptr.5094

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  3 in total

1.  The in vitro and in vivo anti-cancer activities of a standardized quassinoids composition from Eurycoma longifolia on LNCaP human prostate cancer cells.

Authors:  Kind Leng Tong; Kit Lam Chan; Sazaly AbuBakar; Bin Seng Low; Hai Qiu Ma; Pooi Fong Wong
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

2.  Herbal-Based Formulation Containing Eurycoma longifolia and Labisia pumila Aqueous Extracts: Safe for Consumption?

Authors:  Bee Ping Teh; Norzahirah Ahmad; Elda Nurafnie Ibnu Rasid; Nor Azlina Zolkifli; Umi Rubiah Sastu Zakaria; Norliyana Mohamed Yusoff; Azlina Zulkapli; Norfarahana Japri; June Chelyn Lee; Hussin Muhammad
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-10

3.  The Effects of Quassinoid-Rich Eurycoma longifolia Extract on Bone Turnover and Histomorphometry Indices in the Androgen-Deficient Osteoporosis Rat Model.

Authors:  Putri Ayu Jayusman; Isa Naina Mohamed; Ekram Alias; Norazlina Mohamed; Ahmad Nazrun Shuid
Journal:  Nutrients       Date:  2018-06-21       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.